A-Z Index
Librarians
Newsletter
Individual Subscriptions
Institutional Subscriptions
About
Site Demo
Advisory Board
Contact Us
Help
Log In
|
Log In via Athens
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
select
select
All AccessMedicine
Images, Video, & Audio
Drug Monographs
Updates
Guidelines
Quick Medical Diagnosis & Treatment
Harrison's Online
CURRENT Medical Diagnosis & Treatment
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Tintinalli's Emergency Medicine
Hurst's The Heart
Enable Autosuggest
Advanced
Search
About
Search
Harrison's Principles of Internal Medicine, 18e
Updates >
11/15/2012: Refractory Crohn’s Disease: Effective Therapy by Inhibition of Interleukin 12 and Interleukin 23
Kurt J. Isselbacher
Distinguished Mallinckrodt Professor of Medicine, Harvard Medical School; Physician and Director, Massachusetts General Hospital Cancer Center, Boston
Topics Discussed:
crohn's disease; inflammatory bowel disease; interleukin-12; interleukin-23; ustekinumab.
Related to Harrison's
Chapter 295. Inflammatory Bowel Disease
;
View in chapter
;
Excerpt:
"
View in chapter
..."
The content above is only an excerpt.
For full access, log into an existing user account below,
purchase
an annual subscription, or
purchase
a short-term subscription to the complete website.
Subscriber Log In:
Username:
Password:
Forgot your Username/Password?
Or